Publications by authors named "R Sena Turk Yilmaz"

Background: The etiology of medial-sided talar osteochondral lesions (OCLs) remains insufficiently understood.

Purpose: To identify anatomical risk factors contributing to the development of unilateral or bilateral OCL of the talus on the medial side, utilizing morphological parameters derived from magnetic resonance imaging (MRI).

Material And Methods: In this retrospective study, 24 ankle MRI scans from 12 patients exhibiting bilateral OCLs of the talar dome on the medial side, 24 ankle MRIs from 24 patients with unilateral medial-sided OCLs, and 24 healthy controls matched for age, sex, and side within each group were analyzed.

View Article and Find Full Text PDF

Artificial intelligence (AI) has evolved from science fiction to a technology infiltrating everyday life. In neurosurgery, clinicians and researchers are exploring ways to implement this powerful tool to improve the safety and efficiency of the perioperative process. Current applications include preoperative diagnosis, intraoperative detection and recommendations, and technical skills assessment and feedback.

View Article and Find Full Text PDF

Background: Sentinel lymph node biopsy (SLNB) is widely used in patients who receive neoadjuvant chemotherapy (NAC). Still, axillary lymph node dissection (ALND) is recommended for patients with any axillary residual disease after NAC. The necessity of ALND in patients with minimal axillary disease is unclear.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the safety of omitting axillary lymph node dissection (ALND) in patients with residual axillary disease after neoadjuvant chemotherapy (NAC), focusing on those treated with sentinel lymph node biopsy (SLNB) or targeted axillary dissection (TAD).
  • An analysis of two multicenter cohorts (MF18-02 and MF18-03) included 501 patients who received regional nodal irradiation and achieved a complete clinical response to NAC.
  • Results showed low recurrence rates (0.4% axillary, 0.8% locoregional) and no significant differences in disease-free or disease-specific survival between SLNB and TAD, suggesting ALND omission is safe if patients receive
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare patients with seronegative and seropositive primary Sjögren's syndrome (pSS) by analyzing their medical records from 2010 to 2023.
  • Key findings revealed that seropositive patients exhibited more extraarticular manifestations, while dry mouth was notably more common in seronegative patients.
  • Additionally, while the two groups showed similar rates of certain complications, seropositive patients accounted for all the deaths observed in the study.
View Article and Find Full Text PDF